Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Processa Pharmaceuticals, Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION - Processa Pharmaceuticals, Inc.huwx_ex311.htm
10-Q - QUARTERLY REPORT - Processa Pharmaceuticals, Inc.huwx_10q.htm


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report of Heatwurx, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2015, as filed with the Securities and Exchange Commission (the “Report”), the undersigned principal executive officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:  May 15, 2015



/s/ Heather Kearns

Heather Kearns, Interim Chief Executive Officer and Interim Chief Financial Officer

(Principal Executive Officer and Principal Financial and Accounting Officer)